PTGER1 and PTGER2 receptors mediate regulation of progesterone synthesis and type 1 11 β-hydroxysteroid dehydrogenase activity by prostaglandin E2 in human granulosa-lutein cells
PTGER1 and PTGER2 receptors mediate regulation of progesterone synthesis and type 1 11 β-hydroxysteroid dehydrogenase activity by prostaglandin E2 in human granulosa-lutein cells
复制标题
DOI:
10.1677/joe-07-0128
复制
发表时间:
2007-09-01
影响因子:
4
通讯作者:
Michael, A. E.
中科院分区:
文献类型:
--
作者:
Chandras, C.;Harris, T. E.;Michael, A. E.
In luteinizing granulosa cells, prostaglandin E-2 (PGE(2)) can exert luteotrophic actions, apparently via the cAMP signalling pathway. In addition to stimulating progesterone synthesis, PGE(2) can also stimulate oxidation of the physiological glucocorticoid, cortisol, to its inactive metabolite, cortisone, by the type 1 11 beta-hydroxysteroid dehydrogenase (11 beta HSD1) enzyme in human granulosa-lutein cells. Having previously shown these human ovarian cells to express functional G-protein coupled, E-series prostaglandin (PTGER)1, PTGER2 and PTGER 4 receptors, the aim of this study was to delineate the roles of PTGER1 and PTGER2 receptors in mediating the effects of PGE2 on steroidogenesis and cortisol metabolism in human granulosa-lutein cells. PGE(2)-stimulated concentration-dependent increases in both progesterone production and cAMP accumulation (by 1.9 +/- 0.1- and 18.7 +/- 6.8-fold respectively at 3000 nM PGE(2)). While a selective PTGER1 antagonist, SC19220, could partially inhibit the steroidogenic response to PGE(2) (by 55.9 +/- 4.1% at 1000 nM PGE(2)), co-treatment with AH6809, a mixed PTGER1/PTGER2 receptor antagonist, completely abolished the stimulation of progesterone synthesis at all tested concentrations of PGE(2) and suppressed the stimulation of cAMP accumulation. Both PGE(2) and butaprost (a preferential PTGER2 receptor agonist) stimulated concentration-dependent increases in cortisol oxidation by 11 beta HSD1 (by 42.5 +/- 3.1 and 40.0 +/- 3.0% respectively, at PGE2 and butaprost concentrations of 1000 nM). Co-treatment with SC19220 enhanced the ability of both PGE(2) and butaprost to stimulate 11 beta HSD1 activity (by 30.2 +/- 0.2 and 30.5 +/- 0.6% respectively), whereas co-treatment with AH6809 completely abolished the 11 beta HSD1 responses to PGE(2) and butaprost. These findings implicate the PTGER2 receptor cAMP signalling pathway in the stimulation of progesterone production and 11 beta HSD1 activity by PGE(2), in human granulosa-lutein cells.